Arrow Mark Colorado Holdings LLC Adagio Therapeutics, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$3.08 - $4.05 $49,310 - $64,840	-16,010 Reduced 7.03%	211,650 $700,000
Q2 2022 Aug 15, 2022	BUY	$2.54 - $4.52 $578,256 - $1.03 Million	227,660 New	227,660 $747,000
Q1 2022 May 16, 2022	SELL	$3.81 - $10.77 $3.9 Million - $11 Million	-1,024,510 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.35 - $47.04 $11.1 Million - $82.2 Million	-1,748,417 Reduced 63.05%	1,024,510 $7.44 Million
Q3 2021 Nov 15, 2021	BUY	$20.88 - $56.08 $57.9 Million - $156 Million	2,772,927 New	2,772,927 $117 Million

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.